Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study

BACKGROUND: Convalescent plasma therapy (CPT) and remdesivir (REM) have been approved for investigational use to treat coronavirus disease 2019 (COVID-19) in Nepal. METHODS: In this prospective, multicentered study, we evaluated the safety and outcomes of treatment with CPT and/or REM in 1315 hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Koirala, Janak, Gyanwali, Pradip, Gerzoff, Robert B, Bhattarai, Saroj, Nepal, Bipin, Manandhar, Rekha, Jha, Runa, Sharma, Sanjib, Sharma, Yuba Raj, Bastola, Anup, Murphy, Holly, Acharya, Subhash, Adhikari, Prabhat, Rajkarnikari, Manita, Vaidya, Karishma M, Panthi, Chhabi L, Bista, Bihungum, Giri, Grishma, Aryal, Shambhu, Pant, Suman, Pokharel, Akritee, Karki, Shristi, Basnet, Sangita, Koirala, Bhagawan, Dhimal, Meghnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379705/
https://www.ncbi.nlm.nih.gov/pubmed/34430672
http://dx.doi.org/10.1093/ofid/ofab391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379705/
https://www.ncbi.nlm.nih.gov/pubmed/34430672
http://dx.doi.org/10.1093/ofid/ofab391

Ejemplares similares